A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
USWM, LLC (dba US WorldMeds)
Baylor College of Medicine
National Institutes of Health Clinical Center (CC)
Dartmouth-Hitchcock Medical Center
Dana-Farber Cancer Institute
Astellas Pharma Inc
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Weill Medical College of Cornell University
UNC Lineberger Comprehensive Cancer Center
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
Weill Medical College of Cornell University
City of Hope Medical Center